Valuation: Molecure S.A.

Market Cap 147M 37.82M 33.59M 31.41M 28.62M 53.89M 3.64B 54.63M 380M 1.85B 142M 139M 5.96B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 116M 29.87M 26.53M 24.81M 22.61M 42.57M 2.88B 43.16M 300M 1.46B 112M 110M 4.7B EV / Sales 2025
19.2x
EV / Sales 2026 * 73.1x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
1 day+0.84%
1 week+3.00%
Current month+4.35%
1 month+12.50%
3 months+23.71%
6 months+36.36%
Current year+9.09%
1 week 6.45
Extreme 6.45
7.36
1 month 6.2
Extreme 6.2
8.6
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.04
3 years 4.98
Extreme 4.98
22.5
5 years 4.98
Extreme 4.98
43.8
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 01/12/2012
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 03/01/2023
Director TitleAgeSince
Director/Board Member - 30/06/2021
Chairman 38 01/06/2023
Director/Board Member - 14/01/2022
Date Insider Type Main position Quantity % Market Cap. Importance
22/12/23 Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
+0.84%+3.00%-2.70%-59.32% 37.82M
+4.16%+3.04%+49.37%+94.17% 74.41B
-1.07%-1.47%+24.52%+78.33% 59.26B
+1.00%-0.49%+4.42%+34.70% 47.14B
-3.02%-5.20%+27.94%+32.51% 42.91B
+0.31%+3.02%+348.95%+643.82% 44.13B
-1.96%-0.33%+7.04%+99.46% 40.79B
+3.32%+3.49%+10.10%+51.23% 30.77B
-2.68%+2.92%+29.63%+22.72% 29.31B
-4.86%-10.66%-26.27%+330.06% 23.71B
Average -0.39%-0.58%+47.30%+132.77% 39.25B
Weighted average by Cap. +0.02%-0.32%+58.03%+145.78%

Financials

2025 2026 *
Net sales 3.9M 1M 891K 833K 759K 1.43M 96.53M 1.45M 10.07M 49.16M 3.76M 3.68M 158M 2M 514K 457K 427K 389K 733K 49.5M 743K 5.17M 25.21M 1.93M 1.89M 80.98M
Net income -21.2M -5.45M -4.84M -4.53M -4.13M -7.77M -525M -7.87M -54.76M -267M -20.46M -20.02M -858M -13M -3.34M -2.97M -2.78M -2.53M -4.76M -322M -4.83M -33.58M -164M -12.55M -12.28M -526M
Net Debt -30.9M -7.94M -7.06M -6.6M -6.01M -11.32M -765M -11.48M -79.82M -390M -29.82M -29.18M -1.25B -1M -257K -228K -214K -195K -366K -24.75M -371K -2.58M -12.61M -965K -944K -40.49M
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
02/10/26 PLN 7.200 +0.84% 30,346
01/10/26 PLN 7.140 +3.48% 74,839
30/09/26 PLN 6.900 +1.77% 37,852
29/09/26 PLN 6.780 +0.89% 81,615
28/09/26 PLN 6.720 -3.86% 84,335
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
7.140PLN
Average target price
12.45PLN
Spread / Average Target
+74.37%

Quarterly revenue - Rate of surprise